Adaptimmune Therapeutics (ADAP), Glaxo (GSK) Expand Immunotherapy Collaboration; Includes Increased Milestones
Tweet Send to a Friend
Adaptimmune Therapeutics plc (Nasdaq: ADAP) and GlaxoSmithKline plc (NYSE: GSK) announced that the companies have expanded the terms of their ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE